Login to Your Account

Financings Roundup

AlloCure Closes $25M Series B for Kidney Injury

By Catherine Shaffer
Staff Writer

Tuesday, April 3, 2012
AlloCure Inc. raised $25 million for a Series B venture financing, welcoming new investor Lundbeckfond Ventures, as well as previous investors SV Life Sciences and Novo A/S.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription